DOYLESTOWN, Pa., May 03, 2018 -- Xspand Products Lab, Inc. (“Xspand”), a full-service product development company, today announced that the company’s shares are scheduled to begin trading on The Nasdaq Capital Market today, May 3, 2018 under the ticker symbol “XSPL”.
Xspand closed its initial public offering on April 30, 2018, selling an aggregate of 1,307,120 shares of its common stock at a public offering price of US$5.00 per share. Proceeds from the initial public offering will be used for partial consideration for potential acquisitions and general working capital.
About Xspand Products Lab, Inc.
Xspand Products Lab, Inc. is a vertically integrated and full-service product development and manufacturing company, including design, sales, fulfillment and shipping. Xspand's model is to provide a risk mitigated platform that connects innovators with companies to bring new products to market. For more information, please visit www.xspandproductslab.com.
Safe Harbor
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While Xspand believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in Xspand's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. Xspand expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.
Investor Relations Contacts:
Greg Falesnik
Managing Director
MZ North America
Direct: 949-385-6449
[email protected]
www.mzgroup.us
Luke Zimmerman
Senior Associate
MZ North America
Direct: 949-259-4987
[email protected]
www.mzgroup.us


Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
World game at war: why some European nations have threatened a World Cup boycott
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



